{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:12:15Z","timestamp":1760299935438,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"am","delay-in-days":389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.schres.2019.05.013","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T09:44:29Z","timestamp":1557827069000},"page":"286-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Methadone and buprenorphine treatments in patients with schizophrenia"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-8948","authenticated-orcid":false,"given":"Alain","family":"Dervaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Plancke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Amariei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Trouiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Tahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret P.","family":"Martinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micka\u00ebl","family":"Naassila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Cottencin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Danel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2019.05.013_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2017.06.039","article-title":"Demographic and clinical correlates of substance use disorders in first episode psychosis","volume":"194","author":"Brunette","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.05.013_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1192\/bjp.bp.105.015784","article-title":"Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis","volume":"190","author":"Caton","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.05.013_bb0015","first-page":"11","article-title":"Cannabis and schizophrenia: demographic and clinical correlates","volume":"29","author":"Dervaux","year":"2003","journal-title":"Encephale"},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.05.013_bb0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.schres.2006.05.006","article-title":"Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction","volume":"86","author":"Dubertret","year":"2006","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2019.05.013_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1192\/bjp.bp.105.014308","article-title":"Psychotic symptom and cannabis relapse in recent-onset psychosis prospective study","volume":"189","author":"Hides","year":"2006","journal-title":"Br. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.05.013_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2006.07.018","article-title":"Substance abuse in first-episode non-affective psychosis","volume":"88","author":"Larsen","year":"2006","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2019.05.013_bb0035","first-page":"82","article-title":"Cannabis use and dependence among French schizophrenic inpatients","volume":"15","author":"Lejoyeux","year":"2014","journal-title":"Front. Psychiatry."},{"issue":"2\u20133","key":"10.1016\/j.schres.2019.05.013_bb0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(02)00523-6","article-title":"Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences","volume":"67","author":"Margolese","year":"2004","journal-title":"Schizophr. Res."},{"issue":"1\u20132","key":"10.1016\/j.schres.2019.05.013_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2011.05.010","article-title":"Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. population","volume":"119","author":"Martins","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.schres.2019.05.013_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/schbul\/16.1.31","article-title":"Prevalence of substance abuse in schizophrenia: demographic and clinical correlates","volume":"16","author":"Mueser","year":"1990","journal-title":"Schizophr Bull."},{"issue":"8","key":"10.1016\/j.schres.2019.05.013_bb0055","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00127-015-1025-2","article-title":"Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study","volume":"50","author":"Nesv\u00e5g","year":"2015","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"1","key":"10.1016\/j.schres.2019.05.013_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.comppsych.2008.06.002","article-title":"Clinical characteristics influencing age at onset in psychotic disorders","volume":"50","author":"Ong\u00fcr","year":"2009","journal-title":"Compr. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.05.013_bb0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1751-7893.2007.00015.x","article-title":"Substance abuse and first-episode schizophrenia-spectrum disorders. The Danish OPUS trial","volume":"1","author":"Petersen","year":"2007","journal-title":"Early Interv. Psychiatry."},{"issue":"6","key":"10.1016\/j.schres.2019.05.013_bb0070","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1017\/S0033291798007399","article-title":"Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients","volume":"28","author":"Rabinowitz","year":"1998","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2019.05.013_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12888-015-0578-7","article-title":"An evaluation of variation in published estimates of schizophrenia prevalence from 1990\u20132013: a systematic literature review","volume":"15","author":"Simeone","year":"2015","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.05.013_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00127-015-1104-4","article-title":"Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study","volume":"51","author":"Toftdahl","year":"2016","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"author":"Trouiller","key":"10.1016\/j.schres.2019.05.013_bb0085"},{"issue":"3","key":"10.1016\/j.schres.2019.05.013_bb0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/schbul\/sbp016","article-title":"Substance use disorders in schizophrenia-clinical implications of comorbidity","volume":"35","author":"Volkow","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.schres.2019.05.013_bb0095","first-page":"892","article-title":"Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis","volume":"39","author":"Wade","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419301744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419301744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:28:43Z","timestamp":1760297323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996419301744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":19,"alternative-id":["S0920996419301744"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2019.05.013","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methadone and buprenorphine treatments in patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2019.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}